AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Low-dose Form Capsule, page-10

  1. 44,238 Posts.
    lightbulb Created with Sketch. 642
    Thats right Luke... no need for pharmaceutical clinical trials, which would take 3-5 years as this has already been done to the satisfaction of TGA. The "clinical trials" done last year were for the suitability of the hard shell caps. This is purely a form of drug delivery which doesn't require extensive pharmaceutical trials.

    Our product is almost ready for market peoples... get ready for revenue! Maybe next qtr.

    PS Ignore SH... he is just a dumper with an ego issue... sad really. but he doesn't know the story.
    Last edited by Scott th Ratbag: 18/02/20
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.